Impact of Disinfectant Strategies on Hospital-Acquired Infections

Risks Associated with Ineffective Disinfection

Improper and ineffective disinfectant strategies in hospitals can increase the risk of patients contracting multidrug-resistant organisms and Clostridium difficile. The study titled “The Benefits of Enhanced Terminal Room Disinfection” seeks to identify the most effective terminal room disinfection methods to help hospitals lower the rates of hospital-acquired infections.

Hospital-Acquired Infections: A Major Concern

Hospital-acquired infections (HAIs) continue to be a significant issue for healthcare professionals and patients alike. Among the most concerning pathogens are multidrug-resistant organisms such as Methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), and Acinetobacter. These organisms are often linked to serious clinical outcomes. Clostridium difficile, known for causing severe diarrhea, is also one of the most prevalent HAIs.

Importance of Effective Terminal Room Disinfection

Given the risks associated with these infections, effective terminal room disinfection—defined as cleaning and disinfecting rooms between patient occupancy—is a critical hospital procedure that requires optimization. The central question remains: which disinfectant strategy is the most effective in mitigating the risk of infections?

Study Overview: The Benefits of Enhanced Terminal Room Disinfection

Study Design and Objectives

The “Benefits of Enhanced Terminal Room Disinfection” study, published in The Lancet, aimed to evaluate the effectiveness of various disinfectant strategies in reducing infection risks. Conducted from April 2012 to July 2014, the study involved nine hospitals across the United States.

Testing Different Disinfectant Strategies

Four disinfectant strategies were tested, including a reference group using quaternary ammonium-containing disinfectants, except in rooms previously occupied by C. difficile patients, which were treated with bleach. The second strategy involved the use of a UV-C device alongside quaternary ammonium disinfectants or bleach for C. difficile rooms. Additional strategies included a bleach-only group and a bleach combined with UV-C group. These strategies were implemented across all nine hospitals over four consecutive seven-month periods.

Study Findings

Patient Inclusion and Outcomes

A total of 21,395 patients met the inclusion criteria for the study. Within this cohort, 4,916 were in the reference group, 5,178 in the UV group, 5,438 in the bleach-only group, and 5,863 in the bleach and UV group. The analysis showed that patients admitted to rooms previously occupied by individuals with multidrug-resistant organisms or C. difficile were 10-30% less likely to acquire the same pathogen if enhanced disinfection strategies, such as UV, bleach, or bleach with UV, were employed.

Comparative Analysis of Disinfectant Strategies

The UV group, which incorporated the UV-C device into the standard cleaning protocol, exhibited the most significant reduction in infection incidence compared to the reference group. However, the incidence of infection in the bleach-only and bleach plus UV groups was similar to the reference group, indicating that adding bleach or a combination with UV did not substantially decrease risks.

Pathogen-Specific Incidence Rates

The researchers also examined the infection rates for specific pathogens. The combination of UV-C devices and bleach did not significantly lower C. difficile infections compared to bleach alone. While MRSA infection rates were comparable across groups, the UV group recorded the lowest incidence of MRSA infections. Furthermore, the use of bleach disinfectants significantly reduced VRE incidence. Due to the limited occurrence of Acinetobacter infections, drawing conclusions about the most effective disinfectant for this bacterium was challenging.

Conclusions and Implications

Significance of Enhanced Disinfection Strategies

The “Benefits of Enhanced Terminal Room Disinfection” study was a comprehensive, multicenter, cluster-randomized trial designed to evaluate the effectiveness of various disinfectant strategies against common hospital-acquired infections. The findings reaffirm the efficacy of enhanced disinfection strategies in reducing the likelihood of infections caused by multidrug-resistant organisms and C. difficile.

Recommendations for Future Practices

The study highlights the effectiveness of UV-C devices in mitigating infection risks, while bleach alone or in combination with UV did not yield additional benefits for C. difficile infections. Overall, the research underscores the critical need for hospitals to adopt the most effective terminal room disinfection strategies. Besides identifying the best disinfectant methods, attention must also be given to the appropriate and effective application of these techniques in healthcare settings.

Written By: Haisam Shah, BSc